PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HTEC vs. ARKG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


HTECARKG
YTD Return-7.03%-29.87%
1Y Return-12.30%-19.87%
3Y Return (Ann)-18.17%-36.98%
Sharpe Ratio-0.66-0.52
Daily Std Dev19.42%40.00%
Max Drawdown-57.53%-80.10%
Current Drawdown-49.73%-79.41%

Correlation

-0.50.00.51.00.9

The correlation between HTEC and ARKG is 0.88, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

HTEC vs. ARKG - Performance Comparison

In the year-to-date period, HTEC achieves a -7.03% return, which is significantly higher than ARKG's -29.87% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%50.00%NovemberDecember2024FebruaryMarchApril
16.80%
0.13%
HTEC
ARKG

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ROBO Global Healthcare Technology and Innovation ETF

ARK Genomic Revolution Multi-Sector ETF

HTEC vs. ARKG - Expense Ratio Comparison

HTEC has a 0.68% expense ratio, which is lower than ARKG's 0.75% expense ratio.


ARKG
ARK Genomic Revolution Multi-Sector ETF
Expense ratio chart for ARKG: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%
Expense ratio chart for HTEC: current value at 0.68% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.68%

Risk-Adjusted Performance

HTEC vs. ARKG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ROBO Global Healthcare Technology and Innovation ETF (HTEC) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HTEC
Sharpe ratio
The chart of Sharpe ratio for HTEC, currently valued at -0.66, compared to the broader market-1.000.001.002.003.004.00-0.66
Sortino ratio
The chart of Sortino ratio for HTEC, currently valued at -0.87, compared to the broader market-2.000.002.004.006.008.00-0.87
Omega ratio
The chart of Omega ratio for HTEC, currently valued at 0.91, compared to the broader market1.001.502.000.91
Calmar ratio
The chart of Calmar ratio for HTEC, currently valued at -0.22, compared to the broader market0.002.004.006.008.0010.00-0.22
Martin ratio
The chart of Martin ratio for HTEC, currently valued at -1.01, compared to the broader market0.0010.0020.0030.0040.0050.0060.00-1.01
ARKG
Sharpe ratio
The chart of Sharpe ratio for ARKG, currently valued at -0.52, compared to the broader market-1.000.001.002.003.004.00-0.52
Sortino ratio
The chart of Sortino ratio for ARKG, currently valued at -0.56, compared to the broader market-2.000.002.004.006.008.00-0.56
Omega ratio
The chart of Omega ratio for ARKG, currently valued at 0.94, compared to the broader market1.001.502.000.94
Calmar ratio
The chart of Calmar ratio for ARKG, currently valued at -0.26, compared to the broader market0.002.004.006.008.0010.00-0.26
Martin ratio
The chart of Martin ratio for ARKG, currently valued at -0.95, compared to the broader market0.0010.0020.0030.0040.0050.0060.00-0.95

HTEC vs. ARKG - Sharpe Ratio Comparison

The current HTEC Sharpe Ratio is -0.66, which roughly equals the ARKG Sharpe Ratio of -0.52. The chart below compares the 12-month rolling Sharpe Ratio of HTEC and ARKG.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50NovemberDecember2024FebruaryMarchApril
-0.66
-0.52
HTEC
ARKG

Dividends

HTEC vs. ARKG - Dividend Comparison

Neither HTEC nor ARKG has paid dividends to shareholders.


TTM2023202220212020201920182017
HTEC
ROBO Global Healthcare Technology and Innovation ETF
0.00%0.00%0.00%0.05%0.00%0.00%0.00%0.00%
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.62%0.85%3.14%1.94%1.34%

Drawdowns

HTEC vs. ARKG - Drawdown Comparison

The maximum HTEC drawdown since its inception was -57.53%, smaller than the maximum ARKG drawdown of -80.10%. Use the drawdown chart below to compare losses from any high point for HTEC and ARKG. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%NovemberDecember2024FebruaryMarchApril
-49.73%
-79.41%
HTEC
ARKG

Volatility

HTEC vs. ARKG - Volatility Comparison

The current volatility for ROBO Global Healthcare Technology and Innovation ETF (HTEC) is 6.21%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 10.52%. This indicates that HTEC experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%NovemberDecember2024FebruaryMarchApril
6.21%
10.52%
HTEC
ARKG